4basebio (LON:4BB) Insider Hansjörg Plaggemars Acquires 1,000 Shares

4basebio PLC (LON:4BB) insider Hansjörg Plaggemars bought 1,000 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was purchased at an average price of GBX 585 per share, for a total transaction of £5,850.

4basebio Stock Performance

4basebio stock traded down GBX 25 on Wednesday, reaching GBX 565. 805 shares of the stock were exchanged, compared to its average volume of 1,444. The company has a current ratio of 2.73, a quick ratio of 3.52 and a debt-to-equity ratio of 201.47. 4basebio PLC has a twelve month low of GBX 520 and a twelve month high of GBX 1,220. The firm has a fifty day moving average price of GBX 609.02 and a two-hundred day moving average price of GBX 739.02. The stock has a market cap of £87.49 million, a PE ratio of -5.71 and a beta of 1.09.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.